{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T09:05:03Z","timestamp":1762160703362},"reference-count":26,"publisher":"Informa Healthcare","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Medical Research and Opinion"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1185\/030079908x292038","type":"journal-article","created":{"date-parts":[[2008,4,16]],"date-time":"2008-04-16T00:49:31Z","timestamp":1208306971000},"page":"1519-1527","source":"Crossref","is-referenced-by-count":7,"title":["Costs and persistence of carbonic anhydrase inhibitor versus alpha\u20112 agonists, associated with beta-blockers, in glaucoma and ocular hypertension: an analysis of the UK\u2011GPRD database"],"prefix":"10.1185","volume":"24","author":[{"given":"A.","family":"Lafuma","sequence":"first","affiliation":[{"name":"Cemka\rBourg-la-ReineFrance"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Berdeaux","sequence":"additional","affiliation":[{"name":"Alcon France\rRueil-MalmaisonFrance"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3197","published-online":{"date-parts":[[2008,4,14]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2005.088666"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2005.081224"},{"key":"CIT0003","first-page":"532","volume":"122","author":"Friedman DS","year":"2004","journal-title":"Eye Diseases Prevalence Research Group. Prevalence of open-angle glaucoma among adults in the United States. Arch Ophthalmol"},{"key":"CIT0004","first-page":"484","volume":"7","author":"Coyle D","year":"1995","journal-title":"The need for a far-sighted policy. Pharmacoeconomics"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1007\/s004170050165"},{"key":"CIT0006","first-page":"283","volume":"13","author":"Denis P","year":"2004","journal-title":"Medical predictive factors of glaucoma treatment costs. J Glaucoma"},{"key":"CIT0007","first-page":"327","volume":"19","author":"Kooner KS","year":"1987","journal-title":"Ann Ophthalmol"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(99)00235-4"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.120.6.701"},{"key":"CIT0012","first-page":"366","volume":"112","author":"The European Glaucoma Prevention Study","year":"2005","journal-title":"Results of the European Glaucoma Prevention Study. Ophthalmology"},{"key":"CIT0014","first-page":"1268","volume":"120","author":"Heijl A","year":"2002","journal-title":"Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.121.1.48"},{"key":"CIT0020","first-page":"168","volume":"13","author":"Whitson JT","year":"2004","journal-title":"2% in patients with glaucoma or ocular hypertension. J Glaucoma"},{"key":"CIT0021","first-page":"225","volume":"4","author":"Hjelmgren J","year":"2001","journal-title":"Health Economics guidelines \u2013 Similarities, differences and some implications. Value Health"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2004.12.026"},{"key":"CIT0023","first-page":"69","volume":"6","author":"Deschaseaux-Voinet C","year":"2003","journal-title":"G. Cost and effectiveness of brinzolamide versus dorzolamide in current practice: an analysis based on the UK-GPRD data base. J Med Econom"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2005.09.011"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2005.04.051"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-9071.2007.01564.x"},{"key":"CIT0027","first-page":"1172","volume":"25","author":"Reardon G","year":"2003","journal-title":"Mozaffari E. Patient persistency with ocular prostaglandin therapy: a population based, retrospective study. Clin Ther"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.07-0290"},{"key":"CIT0029","first-page":"1599","volume":"114","author":"Quigley HA","year":"2007","journal-title":"Hahn SR. Evaluation of practice patterns for care of open-angle glaucoma compared with claims data: the Glaucoma Adherence and Persistency Study. Ophthalmology"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200321030-00005"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2004.12.026"},{"issue":"1","key":"CIT0037","first-page":"S17","volume":"137","author":"Platt R","year":"2004","journal-title":"Observed time between prescription refills for newer ocular hypotensive agents: the effect of bottle size. Am J Ophthalmol"},{"key":"CIT0039","doi-asserted-by":"publisher","DOI":"10.1097\/00055735-200304000-00001"}],"container-title":["Current Medical Research and Opinion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1185\/030079908X292038","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,2,7]],"date-time":"2018-02-07T10:34:24Z","timestamp":1517999664000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1185\/030079908X292038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4,14]]},"references-count":26,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2008,4,8]]},"published-print":{"date-parts":[[2008,5]]}},"alternative-id":["10.1185\/030079908X292038"],"URL":"https:\/\/doi.org\/10.1185\/030079908x292038","relation":{},"ISSN":["0300-7995","1473-4877"],"issn-type":[{"value":"0300-7995","type":"print"},{"value":"1473-4877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,4,14]]}}}